30-Jun-11 | 30-Jun-10 | 30-Jun-09 | 30-Jun-08 | |||||
---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Total | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Profit Before Tax | ||||||||
UK | (0.63) | 100% | (0.64) | 100% | n/a | n/a | n/a | n/a |
Unanalysed | n/a | n/a | n/a | n/a | (1.16) | 100% | (2.94) | 100% |
Total | (0.63) | 100% | (0.64) | 100% | (1.16) | 100% | (2.94) | 100% |
30-Jun-11 | 30-Jun-10 | 30-Jun-09 | 30-Jun-08 | |||||
---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Total | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Profit Before Tax | ||||||||
Cancer Drug | (0.63) | 100% | (0.64) | 100% | n/a | n/a | n/a | n/a |
Total | (0.63) | 100% | (0.64) | 100% | (1.16) | n/a | (2.94) | n/a |
You are here: research